News MimiVax and Roswell Park Announce Results from Phase 2b SURVIVE Trial of SurVaxM in Newly Diagnosed Glioblastoma
News Improved Stem Cell Transplant Outcomes Achieved at Roswell Park; Named Optum Center of Excellence